As of 06 Nov 2026 02:30 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/023 (05 May 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Midazolam (Buccolam® and generic) 7.5mg/1.5ml oromucosal solution pre-filled oral syringesnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 05 May 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Midazolam (Buccolam® and generic) 7.5mg/1.5ml oromucosal solution pre-filled oral syringes — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Midazolam
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2023 — a recurring shortage spanning 2.6 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 05 May 2026 | Medicine Supply Notification: Midazolam (Epistatus® ) 7.5mg/0.75ml oromucosal solution pre-filled oral syringes sugar free | Supply notification | Tier 2 | MSN/2026/023 |
| 27 Feb 2024 | Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes | Supply notification | Tier 2 | MSN/2024/025 |
| 14 Sep 2023 | Medicine Supply Notification: Midazolam (Epistatus® ) 2.5mg/0.25ml and 10mg/1ml oromucosal solution pre-filled oral syringes | Supply notification | Tier 2 | MSN/2023/086 |
Also recorded under
Bracketed names seen in this medicine's notice titles: epistatus. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)16 Midazolam (Epistatus®) 7.5mg/0.75ml oromucosal solution pre-filled oral syringes · issued 07 May 2026 · valid until late-May 2026, as stated · matched by name PDF ↗
- MSAN(2024)3 Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes · issued 29 Feb 2024 · valid until TBC, as stated · matched by name PDF ↗
- MSAN(2023)27 Midazolam (Epistatus®) 2.5mg/0.25mL and 10mg/1mL oromucosal solution pre- · issued 29 Sep 2023 · valid until late November 2023, as stated · matched by name PDF ↗
- MSAN(2021)4 Midazolam 10mg/2ml solution for injection ampoules · issued 02 Mar 2021 · valid until until April 2021, as stated · matched by name PDF ↗
- MSAN(2019)25 Midazolam (5mg/ml) 50mg in10ml solution for injection ampoules · issued 09 Dec 2019 · valid until 31 January 2020, as stated · matched by name PDF ↗